Please login to the form below

Not currently logged in
Email:
Password:

Stephen MacMillan resigns as Stryker’s chair, president and CEO

Curt Hartman takes over as interim CEO and William Parfet steps in as non-executive chairman at the US medical technology firm

Stephen MacMillan has resigned from his roles as chair, president and CEO of Stryker Corporation.

The US-based medical technology firm cited family reasons as the motivation for the departure of MacMillan, who had been chair for two years, CEO for seven years and president for nine years.

MacMillan said: "It has been an enormous privilege to have led Stryker during this period of important change and growth.

“As I look ahead to the next chapter in my life, I remain confident that the team will continue to execute Stryker's strategy with distinction and that the company will enjoy continued success in the future."

Replacing MacMillan as interim CEO is Stryker's current chief financial officer, Curt Hartman, while lead independent director William Parfet will take over as non-executive chairman.

Hartman, who has been with the company since 1990, has served as chief financial officer and vice president since 2009 and his previous roles include holding the post of global president of Stryker Instruments.

Parfet has been a director at Stryker for almost 20 years alongside his role as chair and CEO of drug safety and pharmaceutical development company MPI Research.

15th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics